Applying Desirability of Outcome Ranking End Points

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 77; no. 1; pp. 159 - 161
Main Authors Dunne, Michael W, Aronin, Steven I, Das, Anita F, Gupta, Jayanti, Akinapelli, Karthik, Zelasky, Michael T, Puttagunta, Sailaja, Boucher, Helen W
Format Journal Article
LanguageEnglish
Published US Oxford University Press 05.07.2023
Subjects
Correspondence
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Previously employed by Iterum Therapeutics.
Potential conflicts of interest. M. W. D. reports stocks, consulting fees, pending patents, and service on the board of directors for Iterum Therapeutics. S. I. A. reports travel support for attending infectious disease conferences, stock options from Iterum Therapeutics, and a board member role with the Connecticut Infectious Disease Society. A. F. D. reports consulting fees from ContraFect, UTILITY, MicuRX, and Paratek and a position on Paratek's data safety monitoring board. S. P. reports stocks and consulting fees from Iterum Therapeutics. H. W. B. reports consulting fees as a publication editor (for Sanford Guide, Infectious Disease Clinics of North America, and Antimicrobial Agents and Chemotherapy) from Sanford Guide, Elsevier, and the American Society of Microbiology. All other authors report no potential conflicts.
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciad166